|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
2.550 +0.005 (+0.196%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 4,478,824 | -1.016% | 4,524,803 | 4,976,334 | 5,114,026 | 3,205,932 |
| Cost of Sales | (3,658,938) | -4.022% | (3,812,276) | (3,939,986) | (4,024,751) | (2,600,472) |
| Gross Profit | 819,886 | 15.067% | 712,527 | 1,036,348 | 1,089,275 | 605,460 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (20,290) | 78.170% | (11,388) | 1,465 | (4,282) | (3,238) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 41,487 | -12.567% | 47,450 | 44,329 | 41,529 | 31,209 | |
| Profit / (Loss) before Taxation | 394,138 | -22.433% | 508,123 | 627,328 | 625,126 | 313,961 | |
| Taxation | (74,750) | -44.164% | (133,875) | (115,673) | (138,258) | (43,365) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (54,486) | 56.898% | (34,727) | (77,706) | (89,191) | (25,927) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 264,902 | -21.978% | 339,521 | 433,949 | 397,677 | 244,669 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 14,998 | -34.452% | 22,881 | 31,618 | 31,521 | 3,091 |
| Depreciation & Amortisation | 289,445 | 0.220% | 288,809 | 302,722 | 289,444 | 188,062 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 21.000 | -22.222% | 27.000 | 34.000 | 31.000 | 19.000 |
| DPS (cts) | 5.000 | -- | 5.000 | 5.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 23.810% | -- | 18.519% | 14.706% | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 5.176 | -- | 4.974 | 4.758 | 4.596 | -- |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 264,902 |
| %Change | -21.978% |
| EPS / (LPS) | RMB 0.210 |
| NBV Per Share (¥) | RMB 5.176 |